{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:51:21Z","timestamp":1769975481753,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108060","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:11:09Z","timestamp":1765037469000},"page":"108060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrating a genotype-based follow-up algorithm in clinical surveillance to mitigate the risk of pancreatitis in patients treated with GLP-1R agonists"],"prefix":"10.1016","volume":"222","author":[{"given":"Angeliki","family":"Margoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108060_bib1","article-title":"Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus","author":"Dungan","year":"2025","journal-title":"UpToDate"},{"issue":"9","key":"10.1016\/j.phrs.2025.108060_bib2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/ph18091261","article-title":"Pharmacogenomics of tirzepatide: genomic insights into dual GIP\/GLP-1 agonist response in type 2 diabetes and atherosclerosis","volume":"18","author":"Song","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.phrs.2025.108060_bib3","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3390\/ijms23073451","article-title":"Glucagon-like peptide-1 receptor agonists in the management of type 2 diabetes mellitus and obesity: the impact of pharmacological properties and genetic factors","volume":"23","author":"Klen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.108060_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.phrs.2025.108060_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pan.2025.06.018","article-title":"Predictors of acute pancreatitis in patients treated with GLP-1 receptor agonists for weight management","volume":"25","author":"Postlethwaite","year":"2025","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.phrs.2025.108060_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/dc16-2684","article-title":"Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight\/obesity and normoglycemia, prediabetes, or type 2 diabetes: secondary analyses of pooled data from the SCALE clinical development program","volume":"40","author":"Steinberg","year":"2017","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.phrs.2025.108060_bib7","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.3390\/ijms25158283","article-title":"Role of interleukin-6 in acute pancreatitis: a possible marker for disease prognosis","volume":"25","author":"Mititelu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.108060_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1515\/cclm-2023-0045","article-title":"ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory-developed tests for in-house use conform requirements of the European In vitro diagnostics regulation","volume":"61","author":"Vanstapel","year":"2023","journal-title":"Clin. Chem. Lab. Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.108060_bib9","article-title":"Expert opinion on NSCLC small specimen biomarker testing: part 2\u2014analytical aspects, quality assurance and reporting","volume":"7","author":"Penault-Llorca","year":"2022","journal-title":"ESMO Open"},{"issue":"13","key":"10.1016\/j.phrs.2025.108060_bib10","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.3390\/ijms26136397","article-title":"Establishing best practices for clinical GWAS: tackling imputation and data quality challenges","volume":"26","author":"Casaburi","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T23:50:15Z","timestamp":1766188215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":10,"alternative-id":["S1043661825004852"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108060","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating a genotype-based follow-up algorithm in clinical surveillance to mitigate the risk of pancreatitis in patients treated with GLP-1R agonists","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108060"}}